Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHINA STATUS III
ChiCTR1900021324Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amlodipine + valsartan in essential hypertension, sponsored by Peking University First Hospital. Primary endpoints: Blood pressure control rate and Treatment persistence and compliance. Started Jul 2013; status: completed.
02
Drugs
amlodipine + valsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR1900021324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021324.